Company / Operating Cash Flow
Steris Operating Cash Flow History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$1.1B
FY2024
5-year range
$684.8M / $1.1B
FY2020-FY2024
Trend
+18.0%
vs FY2023
Sector context
#31 of 158
Health Care
What the data says
Steris's operating cash flow of $1.1B is higher than 80% of companies in the Health Care sector (FY2024). Operating Cash Flow has increased for 3 consecutive years, from $685M in FY2021 to $1.1B in FY2024.
Based on SEC 10-K filings.
$1.1B in FY2024 with a 5-year CAGR of +14.2%. Top quartile in the Health Care sector.
Improved from $757M to $1.1B over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +18.8%
- 5-Year CAGR
- +14.2%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 158This company $1.1B Sector average $1.0B
▼
+11.2% above sector average
Key checks
Key Insights
- Steris's operating cash flow has grown for 3 consecutive years.
- 5-year CAGR of +14.2%, indicating consistent growth.
- In FY2024, operating cash flow increased 18.0% year-over-year.
- Ranks #31 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.1B | +18.0% |
| FY2023 | $973.3M | +28.6% |
| FY2022 | $756.9M | +10.5% |
| FY2021 | $684.8M | -0.7% |
| FY2020 | $689.6M | +16.8% |
| FY2019 | $590.6M | +9.5% |
| FY2018 | $539.5M | - |
| FY2017 | - | - |
| FY2016 | $424.1M | - |
As of FY2024 · SEC 10-K · Updated Mar 13, 2026